ANTICOAGULATION BEFORE AND AFTER CARDIOVERSION OR ABLATION. CHALLENGES, PROBLEMS AND MISTAKES

Agnė Česnauskaitė, Andrius Montrimas, Diana Rinkūnienė, Aras Puodžiukynas Abstract Background: Limited data exists addressing the daily use of anticoagulants for atrial fibrillation (AF) and atrial flutter (AFL) patients before and after electrical cardioversion (ECV) or catheter ablation procedures. The purpose of the study was to evaluate the appropriateness of anticoagulant therapy. Methods: We evaluated the…

New Oral Anticoagulant – Dabigatran – Safety And Efficiency In Patients Receiving Electrical Cardioversion

Pranas Šerpytis, Rasa Palšauskaitė, Giedrius Navickas, Tomas Tamošiūnas, Rokas Šerpytis, Viktoras Skromovas, Dimitrijus Kačiūrinas, Eglė Butkutė Abstract Atrial fibrillation (AF) is the most common arrhythmia. One of the AF medical treatment option is electrical cardiovertion. This procedure may cause ischaemic thromboembolic complications, therefore patients have to use anticoagulants. The main aim of our study was…